• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国一级和二级预防不足对心血管疾病死亡率的相对影响。

The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States.

作者信息

Qureshi Adnan I, Suri M Fareed K, Kirmani Jawad F, Divani Afshin A

机构信息

Zeenat Qureshi Stroke Research Center, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103-2425, USA.

出版信息

Stroke. 2004 Oct;35(10):2346-50. doi: 10.1161/01.STR.0000141417.66620.09. Epub 2004 Sep 2.

DOI:10.1161/01.STR.0000141417.66620.09
PMID:15345797
Abstract

BACKGROUND AND PURPOSE

We developed a model to estimate the costs incurred by ineffective primary and secondary prevention in terms of excess cardiovascular disease (CVD) mortality in a nationally representative sample of the US population.

METHODS

Cox proportional hazards analyses were used to examine the effect of inadequate risk factor control on the incidence of fatal stroke and myocardial infarction (MI) during a follow-up period of 13.4+/-3.6 years after adjusting for differences in age, gender, and ethnicity in a national cohort of 9252 adults who participated in the Second National Health and Nutrition Examination Survey (NHANES) Mortality Follow-up Study. Inadequate risk factor modification was defined by presence of either blood pressure >140/90 mm Hg, serum cholesterol >200 mg/dL, or active cigarette smoking. Using the data from 4115 adults screened in the NHANES 1999 to 2000, population attributable risk (PAR) percent and associated cost incurred (expressed as proportion of total 1-year cost incurred for CVD mortality in year 2001) was estimated.

RESULTS

CVD mortality risk increased in a stepwise manner for persons with no previous MI or stroke and > or =2 inadequately controlled risk factors (2x); and previous history of MI and stroke and adequately controlled risk factors (2.6x), 1 inadequately controlled risk factor (4.3x), and > or =2 inadequately controlled risk factors (5.7x). The PAR was 14% (estimated cost incurred 13.2 billion dollars) among persons with > or =2 inadequately controlled risk factors without previous MI or stroke (estimated 17% of total US population). Among persons with previous MI or stroke, the PAR was 7% (cost incurred 6.2 billion dollars) and 8% (cost incurred 7.4 billion dollars) for 1 inadequately controlled risk factor and > or =2 inadequately controlled risk factors, respectively. An excess of cost of 13.6 billion dollars was spent on 4% of the total population (persons with inadequate secondary prevention).

CONCLUSIONS

The model demonstrates the differential risk of mortality from inadequately controlled cardiovascular risk factors in primary and secondary prevention settings. The large financial cost incurred by inadequate primary and secondary prevention justifies intensive efforts directed toward detection and treatment of cardiovascular risk factors.

摘要

背景与目的

我们开发了一个模型,用以估算在美国具有全国代表性的人群样本中,因一级和二级预防无效导致心血管疾病(CVD)超额死亡所产生的成本。

方法

在一项针对9252名参与第二次全国健康与营养检查调查(NHANES)死亡率随访研究的成年人全国队列中,在调整年龄、性别和种族差异后,采用Cox比例风险分析来检验危险因素控制不充分对13.4±3.6年随访期内致命性卒中和心肌梗死(MI)发生率的影响。危险因素改善不充分的定义为收缩压>140/90 mmHg、血清胆固醇>200 mg/dL或当前吸烟。利用1999年至2000年NHANES中4115名成年人的筛查数据,估算人群归因风险(PAR)百分比及相关成本(以2001年CVD死亡的1年总成本的比例表示)。

结果

对于既往无MI或卒中且有≥2个危险因素控制不充分的人群(2倍);以及既往有MI和卒中病史且危险因素控制充分的人群(2.6倍)、1个危险因素控制不充分的人群(4.3倍)和≥2个危险因素控制不充分的人群(5.7倍),CVD死亡风险呈逐步上升趋势。在既往无MI或卒中且有≥2个危险因素控制不充分的人群中(估计占美国总人口的17%),PAR为14%(估计成本为132亿美元)。在既往有MI或卒中的人群中,对于1个危险因素控制不充分和≥2个危险因素控制不充分的人群,PAR分别为7%(成本为62亿美元)和8%(成本为74亿美元)。在占总人口4%的人群(二级预防不充分的人群)上额外花费了136亿美元。

结论

该模型表明了在一级和二级预防环境中,心血管危险因素控制不充分导致的不同死亡风险。一级和二级预防不充分所产生的巨大经济成本证明了针对心血管危险因素的检测和治疗进行强化努力的合理性。

相似文献

1
The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the United States.美国一级和二级预防不足对心血管疾病死亡率的相对影响。
Stroke. 2004 Oct;35(10):2346-50. doi: 10.1161/01.STR.0000141417.66620.09. Epub 2004 Sep 2.
2
Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.预测5年内心血管疾病和中风的人群水平风险降低对急性住院率的影响——一项试点研究。
Public Health. 2006 Dec;120(12):1140-8. doi: 10.1016/j.puhe.2006.10.012. Epub 2006 Nov 3.
3
Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey.美国人群中心血管事件幸存者的二级预防效果不佳:第三次全国健康与营养检查调查的报告
Arch Intern Med. 2001 Jul 9;161(13):1621-8. doi: 10.1001/archinte.161.13.1621.
4
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.韩国心血管健康干预个体化微观模拟模型评估韩国人群进行心血管疾病一级预防应用他汀类药物治疗的成本效果分析结果
Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8. doi: 10.1016/j.clinthera.2009.12.013.
5
Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.评估固定剂量氨氯地平和阿托伐他汀单片用于韩国心血管疾病一级预防的成本效益的马尔可夫模型分析结果。
Clin Ther. 2009 Oct;31(10):2189-203; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.015.
6
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
7
Cocaine use and the likelihood of cardiovascular and all-cause mortality: data from the Third National Health and Nutrition Examination Survey Mortality Follow-up Study.可卡因使用与心血管疾病及全因死亡率的可能性:来自第三次全国健康与营养检查调查死亡率随访研究的数据。
J Vasc Interv Neurol. 2014 May;7(1):76-82.
8
The impact of prevention on reducing the burden of cardiovascular disease.预防对减轻心血管疾病负担的影响。
Circulation. 2008 Jul 29;118(5):576-85. doi: 10.1161/CIRCULATIONAHA.108.190186. Epub 2008 Jul 7.
9
REDUCE-IT Eligibility and Preventable Cardiovascular Events in the US Population (from the National Health and Nutrition Examination Survey [NHANES]).美国人群中REDUCE-IT的纳入标准及可预防的心血管事件(来自国家健康与营养检查调查[NHANES])
Am J Cardiol. 2020 Nov 1;134:62-68. doi: 10.1016/j.amjcard.2020.08.015. Epub 2020 Aug 16.
10
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.代谢综合征对美国成年人冠心病、心血管疾病及全因死亡率的影响。
Circulation. 2004 Sep 7;110(10):1245-50. doi: 10.1161/01.CIR.0000140677.20606.0E. Epub 2004 Aug 23.

引用本文的文献

1
The economic burden of ischaemic heart diseases on health systems: a systematic review.缺血性心脏病对卫生系统的经济负担:一项系统评价。
BMJ Glob Health. 2025 Feb 12;10(2):e015043. doi: 10.1136/bmjgh-2024-015043.
2
Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review.更新视角下的生活方式干预作为二级卒中预防措施:叙事性综述。
Medicina (Kaunas). 2024 Mar 19;60(3):504. doi: 10.3390/medicina60030504.
3
Lifestyle Modification for Secondary Stroke Prevention.二级卒中预防的生活方式改变
Am J Lifestyle Med. 2016 Feb 21;12(2):140-147. doi: 10.1177/1559827616633683. eCollection 2018 Mar-Apr.
4
Primary and comprehensive stroke centers: history, value and certification criteria.一级和综合卒中中心:历史、价值和认证标准。
J Stroke. 2013 May;15(2):78-89. doi: 10.5853/jos.2013.15.2.78. Epub 2013 May 31.
5
Health improvement and prevention study (HIPS) - evaluation of an intervention to prevent vascular disease in general practice.健康促进与预防研究(HIPS)-评估一项在全科医疗中预防血管疾病的干预措施。
BMC Fam Pract. 2010 Aug 5;11:57. doi: 10.1186/1471-2296-11-57.
6
A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study.一项评价社区药房干预对他汀类药物依从性影响的实用集群随机试验:社区药房协助全面心血管健康(CPATCH)研究的原理和设计。
Trials. 2010 Jul 8;11:76. doi: 10.1186/1745-6215-11-76.
7
Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians.家庭医生与社区药剂师合作提高慢性病患者服药依从性:萨斯喀彻温省家庭医生的观点。
Can Fam Physician. 2009 Dec;55(12):e69-75.
8
A multicenter comparison of outcomes associated with intravenous nitroprusside and nicardipine treatment among patients with intracerebral hemorrhage.脑出血患者静脉注射硝普钠和尼卡地平治疗相关结局的多中心比较。
Neurocrit Care. 2009;11(1):50-5. doi: 10.1007/s12028-009-9192-1. Epub 2009 Feb 18.
9
[Profile of the patient with inadequate follow-up and control of cardiovascular risk factors after suffering an acute myocardial infarction].[急性心肌梗死后心血管危险因素随访及控制不足患者的概况]
Aten Primaria. 2008 Oct;40(10):497-503. doi: 10.1157/13127230.
10
Evidence-based educational guidelines for stroke survivors after discharge home.出院回家后中风幸存者的循证教育指南。
J Neurosci Nurs. 2008 Jun;40(3):173-9, 191. doi: 10.1097/01376517-200806000-00008.